Mitsuo Ikebe Selected Research

Mitsuo Ikebe Research Topics

Disease

6	Fibrosis (Cirrhosis) 04/2022 - 06/2015
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022 - 04/2015
3	type 1B Usher syndrome 07/2015 - 05/2009
2	Neoplasms (Cancer) 06/2022 - 09/2016
2	Empyema 01/2022 - 01/2019
2	Inflammation (Inflammations) 10/2021 - 12/2016
2	Pneumonia (Pneumonitis) 11/2017 - 03/2016
2	Breast Neoplasms (Breast Cancer) 09/2016 - 01/2016
2	Lung Injury 03/2016 - 04/2015
2	Stroke (Strokes) 09/2009 - 02/2006
2	Deafness (Deaf Mutism) 03/2006 - 07/2004
2	Portal Hypertension 02/2006 - 05/2004
1	Cicatrix (Scar) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Pleurisy (Pleuritis) 01/2021
1	Wounds and Injuries (Trauma) 01/2017
1	Usher Syndromes (Usher Syndrome) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 10/2016
1	Infections 10/2016
1	Pulmonary Tuberculosis 10/2016
1	Prostatic Neoplasms (Prostate Cancer) 06/2016
1	Hyperplasia 06/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Lung Diseases (Lung Disease) 04/2015
1	Hearing Loss (Hearing Impairment) 07/2014
1	Vascular Remodeling 05/2014
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 12/2009
1	Type Ib Usher Syndrome 09/2008
1	Hypertension (High Blood Pressure) 02/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2009
6	Myosin VIIaIBA 01/2017 - 03/2006
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 04/2015
4	CollagenIBA 04/2022 - 04/2015
4	Myosins (Myosin)IBA 01/2019 - 05/2009
3	SootIBA 01/2022 - 06/2015
3	Protein Isoforms (Isoforms)IBA 02/2008 - 05/2004
2	caveolin-1 (82-101)IBA 03/2022 - 03/2016
2	CalponinsIBA 01/2022 - 01/2019
2	Plasminogen Activator Inhibitor 1IBA 03/2016 - 04/2015
2	Myosin-Light-Chain PhosphataseIBA 02/2008 - 05/2004
1	fascinIBA 06/2022
1	Fibronectins (Fibronectin)IBA 04/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	CateninsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Oxygen (Dioxygen)IBA 10/2021
1	Thrombin FDA Link 01/2021
1	myocardinIBA 01/2019
1	Glycogen Synthase KinasesIBA 11/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	Dinoprostone (PGE2)FDA Link 12/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2016
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2016
1	CytokinesIBA 10/2016
1	Streptozocin (Streptozotocin)FDA Link 10/2016
1	Cadherins (E-Cadherin)IBA 09/2016
1	VimentinIBA 09/2016
1	Mitochondrial DNA (mtDNA)IBA 06/2016
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 06/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	SmokeIBA 03/2016
1	Tumor Suppressor Protein p53IBA 03/2016
1	CXC ChemokinesIBA 03/2016
1	Interleukin-8B ReceptorsIBA 03/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Cytochromes c (Cytochrome c)IBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 06/2015
1	Protein Kinases (Protein Kinase)IBA 05/2014
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2008
1	Adenosine Triphosphate (ATP)IBA 02/2006
1	Adenosine Diphosphate (ADP)IBA 07/2004
1	myosin VIIBA 07/2004

Therapy/Procedure

1	Ligation 05/2004